Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F G Hamel

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Advances in Second Messenger and Phosphoprotein Research|January 1, 1990
Cellular and endosomal insulin degradationW C Duckworth, F G Hamel
Biochemical and Biophysical Research Communications|September 30, 1982
Solubilization of hormone-responsive adenylate cyclase from human renal cortexF G Hamel, S F Queener
Molecular and Cellular Biochemistry|December 6, 1995
The relationship between insulin and vanadium metabolism in insulin target tissuesF G Hamel, W C Duckworth
International Journal of Pharmaceutics|June 11, 1999
Transdermally delivered peroxovanadium can lower blood glucose levels in diabetic ratsR M Brand, F G Hamel
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1990
Chemotactic factor inactivator interaction with Gc-globulin (vitamin D-binding protein). A mechanism of modulating the chemotactic activity of C5aR A Robbins, F G Hamel
Archives of Biochemistry and Biophysics|May 23, 2001
Characterization of the inhibition of protein degradation by insulin in L6 cellsJ Fawcett, F G Hamel, W C Duckworth
The Journal of Biological Chemistry|September 7, 2000
Degradation of amylin by insulin-degrading enzymeR G Bennett, W C Duckworth, F G Hamel
Diabetes|February 1, 1997
Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complexR G Bennett, F G Hamel, W C Duckworth
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|February 1, 1997
The significance of intracellular insulin to insulin actionW C Duckworth, R G Bennett, F G Hamel
Lipids|October 1, 1983
Changes in renal phospholipid fatty acids in diabetes mellitus: correlation with changes in adenylate cyclase activityD L Clark, F G Hamel, S F Queener
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Advances in Second Messenger and Phosphoprotein Research|January 1, 1990
Cellular and endosomal insulin degradationW C Duckworth, F G Hamel
Biochemical and Biophysical Research Communications|September 30, 1982
Solubilization of hormone-responsive adenylate cyclase from human renal cortexF G Hamel, S F Queener
Molecular and Cellular Biochemistry|December 6, 1995
The relationship between insulin and vanadium metabolism in insulin target tissuesF G Hamel, W C Duckworth
International Journal of Pharmaceutics|June 11, 1999
Transdermally delivered peroxovanadium can lower blood glucose levels in diabetic ratsR M Brand, F G Hamel
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1990
Chemotactic factor inactivator interaction with Gc-globulin (vitamin D-binding protein). A mechanism of modulating the chemotactic activity of C5aR A Robbins, F G Hamel
Archives of Biochemistry and Biophysics|May 23, 2001
Characterization of the inhibition of protein degradation by insulin in L6 cellsJ Fawcett, F G Hamel, W C Duckworth
The Journal of Biological Chemistry|September 7, 2000
Degradation of amylin by insulin-degrading enzymeR G Bennett, W C Duckworth, F G Hamel
Diabetes|February 1, 1997
Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complexR G Bennett, F G Hamel, W C Duckworth
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|February 1, 1997
The significance of intracellular insulin to insulin actionW C Duckworth, R G Bennett, F G Hamel
Lipids|October 1, 1983
Changes in renal phospholipid fatty acids in diabetes mellitus: correlation with changes in adenylate cyclase activityD L Clark, F G Hamel, S F Queener
Pageof 6